Xenetic Biosciences XBIO
NASDAQ XBIO
$2.23 -0.09 (-3.88%)
As of: Oct 1, 2026 · 3:59 PM EDT

Xenetic Biosciences (XBIO) EV to FCF (2017)

Updated

Xenetic Biosciences' (XBIO) EV to FCF stood at 7.49 in Q4 2017.

Analysis

Xenetic Biosciences (XBIO) EV to FCF (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Xenetic Biosciences 5.44 Mn -20.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 7.49
API Access

Xenetic Biosciences EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=XBIO&period=max&api_key=YOUR_API_KEY